NCT06220942View on ClinicalTrials.gov

Tachycardia as an Indication for Prophylactic Phenylephrine Injection in Caesarean Section Under Spinal Anesthesia; an Observational Study

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

May 31, 2024

Conditions
Anesthesia
Interventions
DRUG

Phenylephrine

Pregnant female presented for C.S. after receiving spinal anesthesia, recording the vital data, phenylephrine will be given in a dose of 50 µg IV immediately if the heart rate increases ≥ 20 % of baseline

Trial Locations (1)

11721

RECRUITING

maha sadek El Derh, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER